Clinical Trial Update: Study of a Single Dose of Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine (SP284) in Japanese Subjects [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating a single-dose SP284 meningococcal polysaccharide diphtheria toxoid conjugate vaccine in Japanese subjects has completed with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningitis
• Meningococcal Infections
• Meningococcal Meningitis

Drugs mentioned

• SP284 meningococcal polysaccharide diphtheria toxoid conjugate vaccine (Meningococcal polysaccharide diphtheria toxoid conjugate vaccine)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Meningitis, Meningococcal Meningitis | Phase 3 | Status: COMPLETED | Results posted: 2013-05-28